Can the COVID-19 Pandemic Improve the Management of Solid Organ Transplant Recipients?
Increased mortality due to SARS-CoV-2 infection was observed among solid organ transplant patients. During the pandemic, in order to prevent and treat COVID-19 infections in this context, several innovative procedures and therapies were initiated within a short period of time. A large number of thes...
Main Authors: | Arnaud Del Bello, Olivier Marion, Jacques Izopet, Nassim Kamar |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/14/9/1860 |
Similar Items
-
Monoclonal Antibody Therapy in Kidney Transplant Recipients With Delta and Omicron Variants of SARS-CoV-2: A Single-Center Case SeriesPlain-Language Summary
by: Guillaume Fernandes, et al.
Published: (2022-06-01) -
Humoral and Cellular Responses to a Delayed Fourth SARS-CoV-2 mRNA-Based Vaccine in Weak Responders to 3 Doses Kidney Transplant Recipients
by: Arnaud Del Bello, et al.
Published: (2022-09-01) -
Hepatitis E Virus Infection in Solid Organ Transplant Recipients, France
by: Sebastien Lhomme, et al.
Published: (2017-02-01) -
Experience in the use of neutralizing monoclonal antibodies in kidney transplant recipients with COVID-19
by: I. G. Kim, et al.
Published: (2023-04-01) -
Characteristics and outcomes of COVID-19 patients presumed to be treated with sotrovimab in NHS hospitals in England
by: Vishal Patel, et al.
Published: (2024-04-01)